| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| ANTARES PHARMA, INC. | Director | Common Stock | 0 | $5.60 | 24 May 2022 | Direct | |
| ANTARES PHARMA, INC. | Director | Stock Option (right to buy) | 0 | 24 May 2022 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| /report/000089924322019797-roche-robert-p-jr-2022-05-24 | ANTARES PHARMA, INC. | 24 May 2022 | 11 | -$939,775 | 4 | Director | 26 May 2022, 17:30 |
| /report/000120919121040339-roche-robert-p-jr-2021-06-10 | ANTARES PHARMA, INC. | 10 Jun 2021 | 2 | +$112,498 | 4 | Director | 14 Jun 2021, 18:25 |